Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

June 01, 1995; Volume 273,Issue 3
  • You have access
    Opioid tolerance in human placenta due to in vitro methadone administration.
    B Cemerikic, R Zamah and M S Ahmed
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 987-994;
  • You have access
    Benzodiazepine-withdrawal-induced gastric emptying disturbances in rats: evidence for serotonin receptor involvement.
    C Bonnafous, P Lefevre and L Bueno
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 995-1000;
  • You have access
    Different mechanisms mediated by dopamine D1 and D2 receptors are involved etiologically in activity-stress gastric lesion of the rat.
    K Nomura, N Maeda, T Yoshino and I Yamaguchi
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1001-1007;
  • You have access
    Receptor subtypes involved in dual effects induced by prostaglandin E2 in circular smooth muscle from dog colon.
    A Botella, M Delvaux, J Fioramonti, J Frexinos and L Bueno
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1008-1014;
  • You have access
    RP 73870, a gastrin/cholecystokinin-B receptor antagonist with potent anti-ulcer activity in the rat.
    C E Pendley, L R Fitzpatrick, A J Capolino, M A Davis, N J Esterline, A Jakubowska, P Bertrand, C Guyon, M C Dubroeucq and G E Martin
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1015-1022;
  • You have access
    Anticonvulsant efficacy/safety properties of 2-amino-N-(1,2-diphenylethyl)acetamide hydrochloride.
    G C Palmer, M L Stagnitto, G E Garske, J J Napier, E W Harris, F C Kaiser, R C Griffith, J H Woodhead, H S White and H H Wolf
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1023-1031;
  • You have access
    Modulation of the activity of central serotoninergic neurons by novel serotonin1A receptor agonists and antagonists: a comparison to adrenergic and dopaminergic neurons in rats.
    A Gobert, F Lejeune, J M Rivet, V Audinot, A Newman-Tancredi and M J Millan
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1032-1046;
  • You have access
    Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition.
    L Y Liu-Chen, H H Yang, S Li and J U Adams
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1047-1056;
  • You have access
    Spinal nonadrenergic imidazoline receptors do not mediate the antinociceptive action of intrathecal clonidine in the rat.
    P J Monroe, D L Smith, H R Kirk and D J Smith
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1057-1062;
  • You have access
    Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra.
    B K Yamamoto, J F Nash and G A Gudelsky
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1063-1070;
  • You have access
    S 16118 (p-guanidobenzoyl-[Hyp3,Thi5,D-Tic7,Oic8]bradykinin) is a potent and long-acting bradykinin B2 receptor antagonist, in vitro and in vivo.
    M Félétou, P Robineau, M Lonchampt, E Bonnardel, C Thurieau, J L Fauchère, P Widdowson, J P Mahieu, B Serkiz and J P Volland
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1071-1077;
  • You have access
    Effects of the bradykinin B2 receptor antagonist S 16118 (p-guanidobenzoyl-[Hyp3,Thi5,D-Tic7,Oic8]bradykinin) in different in vivo animal models of inflammation.
    M Félétou, M Lonchampt, P Robineau, I Jamonneau, C Thurieau, J L Fauchère, P Villa, P Ghezzi, J F Prost and E Canet
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1078-1084;
  • You have access
    Effects of caffeine on ventilation during acute and chronic nicotine administration in rhesus monkeys.
    L L Howell
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1085-1094;
  • You have access
    Effects on atrial repolarization of the interaction between K+ channel blockers and muscarinic receptor stimulation.
    A Zaza, G Malfatto and P J Schwartz
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1095-1104;
  • You have access
    Antiproliferative effects of delta opioids on highly purified CD4+ and CD8+ murine T cells.
    N A Shahabi and B M Sharp
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1105-1113;
  • You have access
    Saturable uptake of a recombinant human granulocyte colony-stimulating factor derivative, nartograstim, by the bone marrow and spleen of rats in vivo.
    T Kuwabara, T Uchimura, K Takai, H Kobayashi, S Kobayashi and Y Sugiyama
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1114-1122;
  • You have access
    Polymeric delivery of the active isomer of misoprostol reduces systemic availability and uterotonic activity.
    G W Gullikson, R F Loeffler, D V Mehrotra, J J Casler, R G Bianchi, R E Schmidt, N Khoshaba and W E Perkins
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1123-1131;
  • You have access
    Modulation of the 5-hydroxytryptamine4 receptor-mediated response by short-term and long-term administration of corticosterone in rat CA1 hippocampal pyramidal neurons.
    S Birnstiel and S G Beck
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1132-1138;
  • You have access
    Serotonin potentiates ethanol-induced excitation of ventral tegmental area neurons in brain slices from three different rat strains.
    M S Brodie, R D Trifunović and S A Shefner
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1139-1146;
  • You have access
    Pharmacological characterization of SB 202235, a potent and selective 5-lipoxygenase inhibitor: effects in models of allergic asthma.
    M C Chabot-Fletcher, D C Underwood, J J Breton, J L Adams, A Kagey-Sobotka, D E Griswold, L A Marshall, H M Sarau, J D Winkler and D W Hay
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1147-1155;
  • You have access
    Cytochrome P-450 2E1 is not the sole catalyst of chlorzoxazone hydroxylation in rat liver microsomes. off.
    Z Jayyosi, D Knoble, M Muc, J Erick, P E Thomas and M Kelley
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1156-1161;
  • You have access
    Role of medullary I1-imidazoline and alpha 2-adrenergic receptors in the antihypertensive responses evoked by central administration of clonidine analogs in conscious spontaneously hypertensive rats.
    J J Buccafusco, C A Lapp, K L Westbrooks and P Ernsberger
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1162-1171;
  • You have access
    Evaluation of cannabinoid receptor binding and in vivo activities for anandamide analogs.
    I B Adams, W Ryan, M Singer, B F Thomas, D R Compton, R K Razdan and B R Martin
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1172-1181;
  • You have access
    Pharmacodynamics of 15(S)-hydroperoxyeicosatetraenoic (15-HPETE) and 15(S)-hydroxyeicosatetraenoic acid (15-HETE) in isolated arteries from guinea pig, rabbit, rat and human.
    H Matsuda, K Miyatake and S E Dahlén
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1182-1189;
  • You have access
    Effects of cicletanine on kidney function. 1. Clearance and micropuncture studies in anesthetized rats.
    J Greven
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1190-1196;
  • You have access
    Effects of cicletanine on kidney function. 2. Role of renal prostaglandins and kinins, and of muscarinic receptors.
    J Greven, A Rahn and E Brändle
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1197-1202;
  • You have access
    The effects of anorectic and aversive agents on deprivation-induced feeding and taste aversion conditioning in rats.
    G N Ervin, L S Birkemo, M F Johnson, L K Conger, J T Mosher and J A Menius
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1203-1210;
  • You have access
    Prenatal cocaine exposure selectively reduces mesocortical dopamine release.
    H Y Wang, J M Yeung and E Friedman
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1211-1215;
  • You have access
    delta 9-Tetrahydrocannabinol modulates antigen processing by macrophages.
    K L McCoy, D Gainey and G A Cabral
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1216-1223;
  • You have access
    [3H]WIN 35,428 ([3H]CFT) binds to multiple charge-states of the solubilized dopamine transporter in primate striatum.
    L M Gracz and B K Madras
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1224-1234;
  • You have access
    Characterization of anandamide- and fluoroanandamide-induced antinociception and cross-tolerance to delta 9-THC after intrathecal administration to mice: blockade of delta 9-THC-induced antinociception.
    S P Welch, L D Dunlow, G S Patrick and R K Razdan
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1235-1244;
  • You have access
    Role of delta opioid receptors in the reinforcing and discriminative stimulus effects of cocaine in rhesus monkeys.
    S S Negus, N K Mello, P S Portoghese, S E Lukas and J H Mendelson
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1245-1256;
  • You have access
    Bradykinin receptor subtypes in rat lung: effect of interleukin-1 beta.
    H Tsukagoshi, E B Haddad, P J Barnes and K F Chung
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1257-1263;
  • You have access
    Electrophysiological effect of BRL-32872, a novel antiarrhythmic agent with potassium and calcium channel blocking properties, in guinea pig cardiac isolated preparations.
    A Bril, J F Faivre, M C Forest, B Cheval, B Gout, P Linée, R R Ruffolo and R H Poyser
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1264-1272;
  • You have access
    Action potentials, ionic currents and cell water in guinea pig ventricular preparations exposed to dimethyl sulfoxide.
    T Ogura, L M Shuba and T F McDonald
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1273-1286;
  • You have access
    Does [3H]2-methoxy-idazoxan (RX 821002) detect more alpha-2-adrenoceptor agonist high-affinity sites than [3H]rauwolscine? A comparison of nine tissues and cell lines.
    W Erdbrügger, M Raulf, T Otto and M C Michel
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1287-1294;
  • You have access
    The nitric oxide synthase inhibitor, L-NG-monomethylarginine, reduces carrageenan-induced pleurisy in the rat.
    W R Tracey, M Nakane, J Kuk, G Budzik, V Klinghofer, R Harris and G Carter
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1295-1299;
  • You have access
    Disposition of the bromosulfophthalein-glutathione conjugate in the isolated perfused rat kidney.
    C A Snel, M M Moons, F G Russel and G J Mulder
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1300-1306;
  • You have access
    Imidazenil, a new anxiolytic and anticonvulsant drug, attenuates a benzodiazepine-induced cognition deficit in monkeys.
    D M Thompson, J Auta, A Guidotti and E Costa
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1307-1312;
  • You have access
    Regulation of ion transport by endothelins in rat colonic mucosa: effects of an ETA antagonist (FR139317) and an ETB agonist (IRL1620).
    M Hosokawa, H Tsukada, S Ueda, M Sakai, M Okuma, K Oda, M Takimoto, T Okada and Y Urade
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1313-1322;
  • You have access
    The effect of carbidopa and entacapone pretreatment on the L-dopa pharmacokinetics and metabolism in blood plasma and skeletal muscle in beagle dog: an in vivo microdialysis study.
    D Deleu, S Sarre, G Ebinger and Y Michotte
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1323-1331;
  • You have access
    Right heart failure impairs hepatic oxygenation and theophylline clearance in rats.
    C Y Ng, P W Angus, H Ghabrial, S T Chou, L Arnolda, D J Morgan and R A Smallwood
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1332-1336;
  • You have access
    Effects of beta adrenoceptor agonists and antagonists on adrenal catecholamine release in response to splanchnic nerve stimulation in anesthetized dogs: role of beta-1 and beta-2 adrenoceptors.
    H Koganei, T Kimura and S Satoh
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1337-1344;
  • You have access
    Buprenorphine antagonism of mu opioids in the rhesus monkey tail-withdrawal procedure.
    E A Walker, G Zernig and J H Woods
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1345-1352;
  • You have access
    Increased sensitivity to mu opiate antinociception in the neonatal rat despite weaker receptor-guanyl nucleotide binding protein coupling.
    R T Windh and C M Kuhn
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1353-1360;
  • You have access
    The ontogeny of mu opiate tolerance and dependence in the rat: antinociceptive and biochemical studies.
    R T Windh, P J Little and C M Kuhn
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1361-1374;
  • You have access
    Effects of a K+ channel blocker on glomerular filtration rate and electrolyte excretion in conscious rats.
    J H Ludens, M A Clark and J A Lawson
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1375-1381;
  • You have access
    Effects of a novel KATP channel blocker on renal tubule function and K channel activity.
    T Wang, W H Wang, G Klein-Robbenhaar and G Giebisch
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1382-1389;
  • You have access
    Characterization of the facilitatory prejunctional purinoceptor on adrenergic nerves of the rabbit ear artery.
    R Ishii, K Shinozuka, M Kunitomo, T Hashimoto and K Takeuchi
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1390-1395;
  • You have access
    Inhibitors of phosphodiesterase IV (PDE IV) increase acid secretion in rabbit isolated gastric glands: correlation between function and interaction with a high-affinity rolipram binding site.
    M S Barnette, M Grous, L B Cieslinski, M Burman, S B Christensen and T J Torphy
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1396-1402;
  • You have access
    A possible involvement of sodium channel blockade of class-I-type antiarrhythmic agents in postischemic contractile recovery of isolated, perfused hearts.
    S Takeo, K Tanonaka, M Hayashi, K Yamamoto, J X Liu, T Kamiyama, N Yamaguchi, A Miura and T Natsukawa
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1403-1409;
  • You have access
    Pharmacological characterization of PD 156707, an orally active ETA receptor antagonist.
    E E Reynolds, J A Keiser, S J Haleen, D M Walker, B Olszewski, R L Schroeder, D G Taylor, O Hwang, K M Welch and M A Flynn
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1410-1417;
  • You have access
    Antagonist properties of LY 165,163 at pre- and postsynaptic dopamine D2, D3 and D1 receptors: modulation of agonist actions at 5-HT1A receptors in vivo.
    M J Millan, J M Rivet, V Audinot, A Gobert, F Lejeune, M Brocco, A Newman-Tancredi, S Maurel-Remy and K Bervoets
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1418-1427;
  • You have access
    mu-, delta- and kappa-opiate receptors mediate antinociception in the rat tail flick test following noxious thermal stimulation of one hindpaw.
    G M Pitcher, K Yashpal, T J Coderre and J L Henry
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1428-1433;
  • You have access
    Characterization of [3H]ABT-418: a novel cholinergic channel ligand.
    D J Anderson, M Williams, J R Pauly, J L Raszkiewicz, J E Campbell, G Rotert, B Surber, S B Thomas, J Wasicak and S P Arneric
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1434-1441;
  • You have access
    Carvedilol, a new vasodilating beta-adrenoceptor blocker, inhibits oxidation of low-density lipoproteins by vascular smooth muscle cells and prevents leukocyte adhesion to smooth muscle cells.
    T L Yue, X Wang, J L Gu, R R Ruffolo and G Z Feuerstein
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1442-1449;
  • You have access
    Characterization and distribution of binding sites for a new neurotensin receptor antagonist ligand, [3H]SR 48692, in the guinea pig brain.
    C Betancur, M Canton, D Gully, G Vela, D Pélaprat and W Rostène
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1450-1458;
  • You have access
    Ontogenically related properties of N-methyl-D-aspartate receptors in rat hippocampal neurons and the age-specific sensitivity of developing neurons to lead.
    K Ishihara, M Alkondon, J G Montes and E X Albuquerque
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1459-1470;
  • You have access
    Nicotinic responses in acutely dissociated rat hippocampal neurons and the selective blockade of fast-desensitizing nicotinic currents by lead.
    K Ishihara, M Alkondon, J G Montes and E X Albuquerque
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1471-1482;
  • You have access
    Rotation and striatal c-fos expression after repeated, daily treatment with selective dopamine receptor agonists and levodopa.
    K E Asin, L Bednarz, A Nikkel and R Perner
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1483-1490;
  • You have access
    Inhibition of interleukin-1 and tumor necrosis factor-alpha synthesis following treatment of macrophages with the kappa opioid agonist U50, 488H.
    S M Belkowski, C Alicea, T K Eisenstein, M W Adler and T J Rogers
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1491-1496;
  • You have access
    Cytotoxicity of acetaminophen in human cytochrome P4502E1-transfected HepG2 cells.
    Y Dai and A I Cederbaum
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1497-1505;
  • You have access
    Specific transcriptional inhibition of bone marrow-derived macrophage tumor necrosis factor-alpha gene expression and protein production using novel enantiomeric carbocyclic nucleoside analogues.
    M Bradshaw, M S Rutherford, B J Hoeper, C D McWhinney, D R Borcherding, L B Schook and C K Edwards
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1506-1518;
  • You have access
    Identification of a novel chemical series that blocks interleukin-1-stimulated metalloprotease activity in chondrocytes.
    S Chandrasekhar, A K Harvey, C P Dell, S J Ambler and C W Smith
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1519-1528;
  • You have access
    Increase of diazepam binding inhibitor mRNA levels in the brains of chronically ethanol-treated and -withdrawn mice.
    M Katsura, S Ohkuma, A Tsujimura and K Kuriyama
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1529-1533;
  • You have access
    Presynaptic gamma-hydroxybutyric acid (GHB) and gamma-aminobutyric acidB (GABAB) receptor-mediated release of GABA and glutamate (GLU) in rat thalamic ventrobasal nucleus (VB): a possible mechanism for the generation of absence-like seizures induced by GHB.
    P K Banerjee and O C Snead
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1534-1543;
  • You have access
    Specific inhibition of the contraction of the rat aorta by estradiol 17 beta.
    G Thomas, K Ito, E Zikic, T Bhatti, C Han and P W Ramwell
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1544-1550;
  • You have access
    Characterization of human liver microsomal UDP-glycosyltransferases using photoaffinity analogs.
    J M Little, R R Drake, R Vonk, F Kuipers, R Lester and A Radominska
    Journal of Pharmacology and Experimental Therapeutics June 1995, 273 (3) 1551-1559;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 273, Issue 3
1 Jun 1995
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics